Astrazeneca Pharma India Q4 Results
- BSE: 506820
- NSE: ASTRAZEN
- ISIN: INE203A01020
- Sector: Major Drugs
BSE
6,455.4
118.50 (1.87%)
118.50 (1.87%)Volume1.48 K
Updated: Mon 25 Nov, 2024 | 15:58:52
NSE
6,457.15137.30 (2.17%)
137.30 (2.17%)Volume14.74 K
Updated: Mon 25 Nov, 2024 | 15:44:21
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Astrazeneca Pharma India Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 383.20 | 249.81 | -% | 284.70 | -% |
| Selling/ General/ Admin Expenses Total | 83.30 | 83.93 | -% | 81.06 | -% |
| Depreciation/ Amortization | 3.76 | 4.13 | -% | 4.25 | -% |
| Other Operating Expenses Total | 36.96 | 37.82 | -% | 45.17 | -% |
| Total Operating Expense | 337.57 | 217.35 | -% | 269.34 | -% |
| Operating Income | 45.63 | 32.46 | -% | 15.36 | -% |
| Net Income Before Taxes | 54.35 | 39.46 | -% | 23.28 | -% |
| Net Income | 39.48 | 29.30 | -% | 17.27 | -% |
| Diluted Normalized EPS | 15.79 | 11.72 | -% | 18.84 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST